CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy

ABSTRACT Despite growing evidence that has declared the importance of circRNAs in neurodegenerative diseases, the clinical significance of circRNAs in dopaminergic (DA) neuronal degeneration in the pathogenesis of Parkinson disease (PD) remains unclear. Here, we performed rRNA-depleted RNA sequencing and detected more than 10,000 circRNAs in the plasma samples of PD patients. In consideration of ROC and the correlation between Hohen-Yahr stage (H-Y stage) and Unified Parkinson Disease Rating Scale-motor score (UPDRS) of 40 PD patients, circEPS15 was selected for further research. Low expression of circEPS15 was found in PD patients and there was a negative positive correlation between the circEPS15 level and severity of PD motor symptoms, while overexpression of circEPS15 protected DA neurons against neurotoxin-induced PD-like neurodegeneration in vitro and in vivo. Mechanistically, circEPS15 acted as a MIR24-3p sponge to promote the stable expression of target gene PINK1, thus enhancing PINK1-PRKN-dependent mitophagy to eliminate damaged mitochondria and maintain mitochondrial homeostasis. Thus, circEPS15 rescued DA neuronal degeneration through the MIR24-3p-PINK1 axis-mediated improvement of mitochondrial function. This study reveals that circEPS15 exerts a critical role in participating in PD pathogenesis, and may give us an insight into the novel avenue to develop potential biomarkers and therapeutic targets for PD. Abbreviations: AAV: adeno-associated virus; DA: dopaminergic; FISH: fluorescence in situ hybridizations; HPLC: high-performance liquid chromatography; H-Y stage: Hohen-Yahr stage; LDH: lactate dehydrogenase; MMP: mitochondrial membrane potential; MPTP/p: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid; NC: negative control; PD: Parkinson disease; PINK1: PTEN induced kinase 1; PBS: phosphate-buffered saline; ROS: reactive oxygen species; SNpc: substantia nigra pars compacta; TEM: transmission electron microscopy; UPDRS: Unified Parkinson’s Disease Rating Scale-motor score

[1]  Z. Zeng,et al.  Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop , 2022, Molecular Cancer.

[2]  D. Erskine,et al.  Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage , 2022, Neurology.

[3]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[4]  Mohamed A. Ragheb,et al.  Mitochondrial quality control in health and in Parkinson's disease. , 2022, Physiological reviews.

[5]  C. Chu,et al.  Neuronal autophagy and mitophagy in Parkinson's disease. , 2021, Molecular aspects of medicine.

[6]  Sonja W. Scholz,et al.  Challenges in the diagnosis of Parkinson's disease , 2021, The Lancet Neurology.

[7]  S. Kadener,et al.  A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress , 2020, EMBO molecular medicine.

[8]  J. Jankovic,et al.  Parkinson’s disease: etiopathogenesis and treatment , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  Guangyu Wu,et al.  Opposing functions of β-arrestin 1 and 2 in Parkinson’s disease via microglia inflammation and Nprl3 , 2020, Cell Death & Differentiation.

[10]  Ling-Ling Chen.  The expanding regulatory mechanisms and cellular functions of circular RNAs , 2020, Nature Reviews Molecular Cell Biology.

[11]  Z. Mei,et al.  Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer , 2020, Molecular Cancer.

[12]  Z. Mei,et al.  Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer , 2020, Molecular Cancer.

[13]  T. Dawson,et al.  PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease , 2020, Molecular Neurodegeneration.

[14]  Hao Wang,et al.  Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection , 2020, Nature Communications.

[15]  Sa Wang,et al.  Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p/CREB pathway in Parkinson's disease. , 2019, Biochemical and biophysical research communications.

[16]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[17]  S. Aoki,et al.  A metabolic profile of polyamines in parkinson disease: A promising biomarker , 2019, Annals of neurology.

[18]  Honghong Yao,et al.  Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease , 2019, Autophagy.

[19]  M. Cairns,et al.  Circular RNAs are temporospatially regulated throughout development and ageing in the rat , 2019, Scientific Reports.

[20]  M. Cairns,et al.  Circular RNA biogenesis is decreased in postmortem cortical gray matter in schizophrenia and may alter the bioavailability of associated miRNA , 2019, Neuropsychopharmacology.

[21]  Zaohuo Cheng,et al.  hsa_circRNA_104597: a novel potential diagnostic and therapeutic biomarker for schizophrenia. , 2019, Biomarkers in medicine.

[22]  Y. Yarden,et al.  The circRNA–microRNA code: emerging implications for cancer diagnosis and treatment , 2019, Molecular oncology.

[23]  H. Bellen,et al.  Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to α-Synuclein Gain. , 2018, Cell metabolism.

[24]  H. Cai,et al.  Parkin and PINK1 mitigate STING-induced inflammation , 2018, Nature.

[25]  L. Qi,et al.  CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson’s disease by targeting miR-7 , 2018, Aging.

[26]  T. Südhof,et al.  Cell Biology and Pathophysiology of α-Synuclein. , 2018, Cold Spring Harbor perspectives in medicine.

[27]  A. Nazir,et al.  Functional Characterization of Novel Circular RNA Molecule, circzip-2 and Its Synthesizing Gene zip-2 in C. elegans Model of Parkinson’s Disease , 2018, Molecular Neurobiology.

[28]  L. Yao,et al.  circHLA-C Plays an Important Role in Lupus Nephritis by Sponging miR-150 , 2017, Molecular therapy. Nucleic acids.

[29]  Walter J. Lukiw,et al.  Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer’s Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7) , 2016, Genes.

[30]  H. McBride,et al.  Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation , 2016, Cell.

[31]  Andrea Califano,et al.  Identification of Neurodegenerative Factors Using Translatome-Regulatory Network Analysis , 2015, Nature Neuroscience.

[32]  J. Hardy,et al.  Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction , 2015, Brain : a journal of neurology.

[33]  E. Schuman,et al.  Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity , 2015, Nature Neuroscience.

[34]  R. Youle,et al.  The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease , 2015, Neuron.

[35]  P. Marin,et al.  Primary culture of mouse dopaminergic neurons. , 2014, Journal of visualized experiments : JoVE.

[36]  Keiji Tanaka,et al.  A Dimeric PINK1-containing Complex on Depolarized Mitochondria Stimulates Parkin Recruitment* , 2013, The Journal of Biological Chemistry.

[37]  R. Youle,et al.  Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. , 2012, Developmental cell.

[38]  Konstanze F. Winklhofer,et al.  Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson’s disease , 2012, Acta Neuropathologica.

[39]  Kindiya D. Geghman,et al.  Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission , 2011, Proceedings of the National Academy of Sciences.

[40]  Jau-Shyong Hong,et al.  Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease , 2011, Environmental health perspectives.

[41]  T. Hashimoto,et al.  Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism , 2010, Neurology.

[42]  R. Burke,et al.  Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.

[43]  N. Hattori,et al.  PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy , 2010, The Journal of cell biology.

[44]  Atsushi Tanaka,et al.  PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.

[45]  J. Andersen,et al.  Cell in focusDopaminergic neurons , 2005 .

[46]  A. Bentivoglio,et al.  PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.

[47]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[48]  Nektarios Tavernarakis,et al.  Mitophagy and Neuroprotection. , 2019, Trends in molecular medicine.

[49]  Mark R. Cookson.  DJ‐1, PINK1, and their effects on mitochondrial pathways , 2010, Movement disorders : official journal of the Movement Disorder Society.

[50]  吉野 浩代.  Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism , 2010 .

[51]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[52]  M. Farrer,et al.  Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study. , 2002, Brain : a journal of neurology.